Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2018ex32-2_citius.htm |
| EX-32.1 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2018ex32-1_citius.htm |
| EX-31.2 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2018ex31-2_citius.htm |
| EX-31.1 - CERTIFICATION - Citius Pharmaceuticals, Inc. | f10k2018ex31-1_citius.htm |
| EX-10.23 - AMENDED AND RESTATED EMPLOYMENT AGREEMENT BETWEEN LEONARD MAZUR AND CITIUS PHARM - Citius Pharmaceuticals, Inc. | f10k2018ex10-23_citius.htm |
| 10-K - ANNUAL REPORT - Citius Pharmaceuticals, Inc. | f10k2018_citiuspharma.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Forms S-1 (333-224386 and 333-226395) and on Form
S-3 (File No. 333-221492) of Citius Pharmaceuticals, Inc. of our report dated December 11, 2018, relating to the consolidated financial
statements of Citius Pharmaceuticals, Inc., appearing in the Annual Report on Form 10-K for the year ended September 30, 2018.
/s/ Wolf & Company, P.C.
Wolf & Company, P.C.
Boston, Massachusetts
December 11, 2018